Empowering Cryonics! Yinfeng Life Extension Program Members' Online Exchange Meeting Successfully Concluded
Release time:
2024-10-30
Exploring life sciences and anticipating future miracles. The Yinfeng Life Extension Program members' online exchange meeting successfully concluded at 9:30 AM. Aaron Drake, Director of the Clinical Response Center at Shandong Yinfeng Life Science Research Institute (hereafter referred to as Yinfeng Institute), and the cryonics team participated in this exchange event.
During the meeting, Aaron Drake introduced members to the history and current status of international human cryopreservation. He mentioned that human cryopreservation is a scientific technique that preserves human life at extremely low temperatures, with the hope that future medical technology will advance enough to cure diseases and reverse aging, allowing for revival. Cryopreservation involves cooling the human body to a low temperature of -196℃, at which all biological activities cease, meaning the body undergoes no changes. Currently, more than 700 people worldwide have undergone cryopreservation, and over 5,000 have pre-registered to participate in cryopreservation when their health begins to fail. Human cryopreservation is not just about freezing people; it is about keeping hope alive for those with terminal illnesses or severe injuries. Although revival is not yet possible, rapid advancements in biology, neuroscience, and artificial intelligence offer hope for realizing this dream.

Yinfeng Institute's Cryonics Department Researcher Hao Yan and Public Affairs Director Li Qingping shared insights into the scientific progress and operational model of the Yinfeng Life Extension Program. In the interactive segment, there was in-depth communication and discussion regarding questions raised by members.
To date, all the achievements and progress of the Yinfeng Life Extension Program are inseparable from the support and encouragement of every member. Whether their roles in society are scientists, engineers, or entrepreneurs, here we are united under one name — members of the Yinfeng Life Extension Program. We share common ideals and goals, as well as shared hopes and watchfulness. In the future, Yinfeng Institute's cryonics team will continue to contribute towards the development of cryobiomedicine alongside all member friends, illuminating our shared dreams with concrete actions.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.